157 related articles for article (PubMed ID: 2509647)
1. The use of indium-111 oxine platelet scintigraphy and survival studies in pediatric patients with thrombocytopenia.
Castle VP; Shulkin BL; Coates G; Andrew M
J Nucl Med; 1989 Nov; 30(11):1819-24. PubMed ID: 2509647
[TBL] [Abstract][Full Text] [Related]
2. Thrombocytopenia in renal transplantation. Diagnostic use of homologous platelet labelling with 111In oxine.
Dodd NJ; Clarke MB; Bewick M; Weston MJ
Nephron; 1983; 34(1):42-4. PubMed ID: 6406919
[TBL] [Abstract][Full Text] [Related]
3. Quantitative platelet imaging and comparison of four mathematical models for the evaluation of platelet mean life span in patients with chronic immune thrombocytopenia.
Amuasi JH; Ferri P; Grossi A; Vannucchi L; Vannucchi AM; Ferrini PR
Haematologica; 1991; 76(2):104-8. PubMed ID: 1937166
[TBL] [Abstract][Full Text] [Related]
4. Metastatic angiosarcoma with thrombocytopenia and intratumoral indium-111-platelet deposition.
Arcomano MA; Shulkin BL; Petry NA; Wahl RL
J Nucl Med; 1991 Dec; 32(12):2278-80. PubMed ID: 1744715
[TBL] [Abstract][Full Text] [Related]
5. Scintigraphy with indium-111-labeled homologous (donor) platelets in the platelet transfusion refractory bone marrow transplant patient.
Hammersmith SM; Jacobson AF; Mankoff DA
J Nucl Med; 1997 Jul; 38(7):1135-8. PubMed ID: 9225806
[TBL] [Abstract][Full Text] [Related]
6. In-111-labeled platelet scintigraphies in patients with chronic hepatitis C.
Wang SJ; Tsai SC; Chen GH; Lan JL; Yen TC
Hepatogastroenterology; 2002; 49(46):1066-8. PubMed ID: 12143203
[TBL] [Abstract][Full Text] [Related]
7. Hemangioma with consumptive coagulopathy (Kasabach-Merritt syndrome) detection by indium-111 oxine-labeled platelets.
Schmidt RP; Lentle BC
Clin Nucl Med; 1984 Jul; 9(7):389-91. PubMed ID: 6432394
[TBL] [Abstract][Full Text] [Related]
8. [Clinical evaluation of 111In-oxine-labeled platelet and 99mTc-HSA-D scintigraphies in Kasabach-Meritte syndrome associated with anterior mediastinal hemangioma: case report].
Asano Y; Ishii K; Sagiuchi T; Kikuchi K; Jinguuji K; Ohta Y; Hayakawa K
Kaku Igaku; 2003 Nov; 40(4):445-9. PubMed ID: 14733109
[TBL] [Abstract][Full Text] [Related]
9. Feasibility of a rapid method to evaluate platelet survival time.
Baroli A; Brambilla M; Antonini G; Ciardi L; Bordin G; Cardani G; Rudoni M; Sacchetti G; Inglese E
J Nucl Med; 1997 Jun; 38(6):977-9. PubMed ID: 9189154
[TBL] [Abstract][Full Text] [Related]
10. Intratumoral consumption of indium-111-labeled platelets in a child with splenic hemangioma and thrombocytopenia.
Pampin C; Devillers A; Treguier C; Fremond B; Moisan A; Goasguen J; Le Gall E
J Pediatr Hematol Oncol; 2000; 22(3):256-8. PubMed ID: 10864058
[TBL] [Abstract][Full Text] [Related]
11. Kinetics and in vivo distribution of 111-In-labelled autologous platelets in chronic hepatic disease: mechanisms of thrombocytopenia.
Schmidt KG; Rasmussen JW; Bekker C; Madsen PE
Scand J Haematol; 1985 Jan; 34(1):39-46. PubMed ID: 3918341
[TBL] [Abstract][Full Text] [Related]
12. Scintigraphic prediction of therapeutic outcomes of splenectomy in patients with thrombocytopenia.
Kinuya K; Matano S; Nakashima H; Taki S
Ann Nucl Med; 2003 Apr; 17(2):161-4. PubMed ID: 12790368
[TBL] [Abstract][Full Text] [Related]
13. The scintigraphic index spleen/liver at 30 minutes predicts the success of splenectomy in persistent and chronic primary immune thrombocytopenia.
Roca M; Muñiz-Diaz E; Mora J; Romero-Zayas I; Ramón O; Roig I; Pujol-Moix N
Am J Hematol; 2011 Nov; 86(11):909-13. PubMed ID: 21948335
[TBL] [Abstract][Full Text] [Related]
14. 111In-tropolonate labelled platelets; studies in normals and in patients with thrombocytopenia.
Louwes H; Beekhuis H; Goedemans WT; Keijser SP; Schuurman JJ
Eur J Nucl Med; 1987; 13(1):47-51. PubMed ID: 3109918
[TBL] [Abstract][Full Text] [Related]
15. 111In-oxine platelet survivals in thrombocytopenic infants.
Castle V; Coates G; Kelton JG; Andrew M
Blood; 1987 Sep; 70(3):652-6. PubMed ID: 3113512
[TBL] [Abstract][Full Text] [Related]
16. [Initial 111In-platelet kinetics: indicator of platelet sequestration/destruction site or quality control of platelet labelling?].
Todorović-Tirnanić M; Obradović V; Rolović Z; Suvajdzić N; Elezović I; Colović M; Pavlović S; Starcević V; Bosnjaković V
Glas Srp Akad Nauka Med; 2005; (48):101-18. PubMed ID: 16405234
[TBL] [Abstract][Full Text] [Related]
17. [Platelet labelling with In-111-oxine: platelet survival and the images].
Conte G; González P; Larraín C; Olea E; Parada X; Hurtado E; Cuneo M
Rev Med Chil; 1990 Jan; 118(1):10-4. PubMed ID: 2152696
[TBL] [Abstract][Full Text] [Related]
18. Platelet survival determined with 51Cr versus 111In.
Kiefel V; Becker T; Mueller-Eckhardt G; Grebe S; Mueller-Eckhardt C
Klin Wochenschr; 1985 Jan; 63(2):84-9. PubMed ID: 3920431
[TBL] [Abstract][Full Text] [Related]
19. Kinetics and distribution in vivo of 111In-labelled autologous platelets in idiopathic thrombocytopenic purpura.
Schmidt KG; Rasmussen JW
Scand J Haematol; 1985 Jan; 34(1):47-56. PubMed ID: 3918342
[TBL] [Abstract][Full Text] [Related]
20. Comparison of oxine and tropolone methods for labeling human platelets with indium-111.
Kotzé HF; Heyns AD; Lötter MG; Pieters H; Roodt JP; Sweetlove MA; Badenhorst PN
J Nucl Med; 1991 Jan; 32(1):62-6. PubMed ID: 1899112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
